Indianapolis, United States
Amplicore Inc., founded in 2019, is a pioneering biotechnology company based in the United States. The company operates in the Biotechnology, Health Care, and Health and Wellness sectors. Its mission, encapsulated in the slogan, "At Amplicore, we develop injectable therapeutics to serve unmet medical needs in musculoskeletal disorders," underscores its commitment to innovative, minimally invasive solutions for degenerative musculoskeletal disorders.
Amplicore differentiates itself by focusing on regenerative approaches to conditions such as joint osteoarthritis and degenerative disc disease, not only alleviating pain but also targeting the root causes of joint discomfort. The company's strategic vision is to convert scientific advancements into practical therapies easily accessible to patients.
The company's latest capital infusion was a $4.00M Seed Round on March 25, 2021, backed by reputable investors including ITIC: Industrial Technology Investment Corporation, Berkeley Catalyst Fund, Photon Fund, and SVE Capital, emphasizing industry confidence in its visionary approach.
DiscGenics